The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...

Retevmo (selpercatinib) is a medicine that is used in adults for certain types of non-small-cell lung cancer (NSCLC) that have a certain fusion in a gene known as receptor tyrosine kinase (RET). This ...

Erratum: Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer The article by Lai et al ...

The next-generation tyrosine kinase inhibitor Augtyro (repotrectinib) represents a new treatment option for patients with locally advanced (cancer that has spread to nearby tissue or lymph nodes) or ...

Daphne Berryhill is an oncology pharmacist and freelance writer. She loves the collaborative process of creating health content. Her goal as a writer is to offer information that’s meaningful, ...

Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Rearranged or Translocated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04) Patients with ...

L-tyrosine is used in supplements to help improve cognitive function during stress. People with PKU may need L-tyrosine supplements alongside a low-phenylalanine diet. L-tyrosine supplements are often ...